Assessment	assessment	O	O	O	O
of	of	O	O	O	O
perinatal	perinatal	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
and	and	O	O	O	O
rubella	rubella	O	O	OTHERS	I
prevention	prevention	O	O	O	O
in	in	O	O	O	O
New	new	O	O	O	O
Hampshire	hampshire	O	O	O	O
delivery	delivery	O	O	O	O
hospitals	hospitals	O	O	O	O
.	.	O	O	O	O

OBJECTIVE	objective	O	O	O	O
:	:	O	O	O	O
To	to	O	O	O	O
evaluate	evaluate	O	O	O	O
current	current	O	O	O	O
performance	performance	O	O	O	O
on	on	O	O	O	O
recommended	recommended	O	O	O	O
perinatal	perinatal	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
and	and	O	O	O	O
rubella	rubella	O	O	OTHERS	I
prevention	prevention	O	O	O	O
practices	practices	O	O	O	O
in	in	O	O	O	O
New	new	O	O	O	O
Hampshire	hampshire	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
Data	data	O	O	O	O
were	were	O	O	O	O
extracted	extracted	O	O	O	O
from	from	O	O	O	O
2021	2021	O	O	O	O
paired	paired	O	O	O	O
mother-infant	mother-infant	O	O	O	O
records	records	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
year	year	O	O	O	O
2000	2000	O	O	O	O
birth	birth	O	O	O	O
cohort	cohort	O	O	O	O
in	in	O	O	O	O
New	new	O	O	O	O
Hampshire	hampshire	O	O	O	O
's	's	O	O	O	O
25	25	O	O	O	O
delivery	delivery	O	O	O	O
hospitals	hospitals	O	O	O	O
.	.	O	O	O	O

Assessment	assessment	O	O	O	O
was	was	O	O	O	O
done	done	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
following	following	O	O	O	O
:	:	O	O	O	O
prenatal	prenatal	O	O	O	O
screening	screening	O	O	O	O
for	for	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
and	and	O	O	O	O
rubella	rubella	O	O	OTHERS	I
,	,	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
vaccine	vaccine	O	O	OTHERS	I
birth	birth	O	O	O	O
dose	dose	O	O	O	O
to	to	O	O	O	O
all	all	O	O	O	O
infants	infants	O	O	O	O
,	,	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
immune	immune	O	O	O	O
globulin	globulin	O	O	O	O
to	to	O	O	O	O
infants	infants	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
born	born	O	O	O	O
to	to	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
surface	surface	O	O	O	O
antigen-positive	antigen-positive	O	O	O	O
mothers	mothers	O	O	O	O
,	,	O	O	O	O
rubella	rubella	O	O	OTHERS	I
immunity	immunity	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
in-hospital	in-hospital	O	O	O	O
postpartum	postpartum	O	O	O	O
rubella	rubella	CHEMICALS	O	OTHERS	I
vaccine	vaccine	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
rubella	rubella	O	O	OTHERS	I
nonimmune	nonimmune	O	O	O	O
women	women	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
Prenatal	prenatal	O	O	O	O
screening	screening	O	O	O	O
rates	rates	O	O	O	O
for	for	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
(	(	O	O	O	O
98.8	98.8	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
rubella	rubella	O	O	OTHERS	I
(	(	O	O	O	O
99.4	99.4	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
high	high	O	O	O	O
.	.	O	O	O	O

Hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
vaccine	vaccine	O	O	OTHERS	I
birth	birth	O	O	O	O
dose	dose	O	O	O	O
was	was	O	O	O	O
administered	administered	O	O	O	O
to	to	O	O	O	O
76.2	76.2	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
all	all	O	O	O	O
infants	infants	O	O	O	O
.	.	O	O	O	O

All	all	O	O	O	O
infants	infants	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
born	born	O	O	O	O
to	to	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
surface	surface	O	O	O	O
antigen-positive	antigen-positive	O	O	O	O
mothers	mothers	O	O	O	O
also	also	O	O	O	O
received	received	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
immune	immune	O	O	O	O
globulin	globulin	O	O	O	O
.	.	O	O	O	O

Multivariate	multivariate	O	O	O	O
logistic	logistic	O	O	O	O
regression	regression	O	O	O	O
showed	showed	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
month	month	O	O	O	O
of	of	O	O	O	O
delivery	delivery	O	O	O	O
and	and	O	O	O	O
infant	infant	O	O	O	O
birth	birth	O	DISEASE	OTHERS	I
weight	weight	O	DISEASE	OTHERS	I
were	were	O	O	O	O
independent	independent	O	O	O	O
predictors	predictors	O	O	O	O
of	of	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
vaccination	vaccination	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
proportion	proportion	O	O	O	O
of	of	O	O	O	O
infants	infants	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
vaccinated	vaccinated	O	O	O	O
in	in	O	O	O	O
January	january	O	O	O	O
and	and	O	O	O	O
February	february	O	O	O	O
2000	2000	O	O	O	O
(	(	O	O	O	O
48.5	48.5	O	O	O	O
%	%	O	O	O	O
and	and	O	O	O	O
67.5	67.5	O	O	O	O
%	%	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
less	less	O	O	O	O
than	than	O	O	O	O
any	any	O	O	O	O
other	other	O	O	O	O
months	months	O	O	O	O
,	,	O	O	O	O
whereas	whereas	O	O	O	O
the	the	O	O	O	O
proportion	proportion	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
vaccinated	vaccinated	O	O	O	O
in	in	O	O	O	O
December	december	O	O	O	O
2000	2000	O	O	O	O
(	(	O	O	O	O
88.2	88.2	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
the	the	O	O	O	O
highest	highest	O	O	O	O
.	.	O	O	O	O

Women	women	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
born	born	O	O	O	O
between	between	O	O	O	O
1971	1971	O	O	O	O
and	and	O	O	O	O
1975	1975	O	O	O	O
had	had	O	O	O	O
the	the	O	O	O	O
highest	highest	O	O	O	O
rate	rate	O	O	O	O
of	of	O	O	O	O
rubella	rubella	O	O	OTHERS	I
nonimmunity	nonimmunity	O	O	O	O
(	(	O	O	O	O
9.5	9.5	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

In-hospital	in-hospital	O	O	O	O
postpartum	postpartum	O	O	O	O
rubella	rubella	CHEMICALS	O	OTHERS	I
vaccine	vaccine	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
was	was	O	O	O	O
documented	documented	O	O	O	O
for	for	O	O	O	O
75.6	75.6	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
nonimmune	nonimmune	O	O	O	O
women	women	O	O	O	O
.	.	O	O	O	O

CONCLUSION	conclusion	O	O	O	O
:	:	O	O	O	O
This	this	O	O	O	O
study	study	O	O	O	O
documents	documents	O	O	O	O
good	good	O	O	O	O
compliance	compliance	O	O	O	O
in	in	O	O	O	O
New	new	O	O	O	O
Hampshire	hampshire	O	O	O	O
's	's	O	O	O	O
birthing	birthing	O	O	O	O
hospitals	hospitals	O	O	O	O
with	with	O	O	O	O
national	national	O	O	O	O
guidelines	guidelines	O	O	O	O
for	for	O	O	O	O
perinatal	perinatal	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
B	b	O	DISEASE	OTHERS	I
and	and	O	O	O	O
rubella	rubella	O	O	OTHERS	I
prevention	prevention	O	O	O	O
and	and	O	O	O	O
highlights	highlights	O	O	O	O
potential	potential	O	O	O	O
areas	areas	O	O	O	O
for	for	O	O	O	O
improvement	improvement	O	O	O	O
.	.	O	O	O	O

